logo
Weightlifting made Casey Johnston stronger — in muscle and mind

Weightlifting made Casey Johnston stronger — in muscle and mind

CBC20-05-2025

Social Sharing
After years of following diets and running a bunch of half-marathons, journalist and editor Casey Johnston finally hit her goal weight of 138 pounds at age 26.
But after all that, she didn't find the happiness or self-confidence she was promised. Instead, she felt deeply hopeless, running on empty.
"I realized I was hoping for this moment when everything would feel like it clicked and I would not have to be trying so hard," she said on Bookends with Mattea Roach. "[Where] it didn't take so much effort and so much of my mental energy and physical energy in order to just be comfortable in my body."
"But I found that the longer it went on, the more kind of maintenance it seemed to take, the more the more energy and the more attention."
That's when she remembered a Reddit post about weightlifting — and decided to try it — despite everything telling her that it wouldn't get her where she wanted to go.
Now, years later, she writes about the unexpected healing she gained from weight training in her book A Physical Education.
She joined Roach to discuss her journey to finding joy and acceptance in her body and, at the same time, her spirit.
Mattea Roach: Where did the priority of optimizing your body come from for you, do you think?
Casey Johnston: I tried to take a really honest inventory over the course of writing this book of how my thoughts have been shaped over and my view of myself and working out and food over the course of my life.
I mean, there's cultural forces. There's the stuff we read in magazines. The ubiquitous presence of celebrity doctors who present themselves as having all of these quick, easy answers. There were, at the time, women's magazines that had so much to say about the best fruits for weight loss etcetera, but then there was also my own family background.
My father was an alcoholic. We all struggled with that. My mother had her own traumatic background and it really created this dynamic of, when I was a child, that I always had to be on my toes. It was very performance-oriented in a way that I felt like I had to maximize my own performance to make everything as okay, as safe as possible for myself. That's not something that kids should have to go through, but it sort of permeated outward into how I saw my place in the world, which was that my role, my job as a person was to be responsive to all of these instructions that I was getting, that I had to produce my own safety and my own place in the world through this hard work of of following all these instructions that people were giving in order for acceptance.
So you're in this spot where running, cardio, dieting is not working for you. You come across this Reddit post that clearly made an impact on you about a woman with a different approach to fitness: weightlifting. What sorts of things did she reveal to you about dieting and strength? What spoke to you in her story?
When I saw this post I was completely blown away by it because I had always been told that lifting weights will make you bulky, that if you just sort of want to lose weight, that lifting weights is sort of a bridge too far unless you want to be some mega-strength person. So I was fascinated when I came across this post.
A lot of times when you see before and after photos, they're about the exaggerated transformation. I was used to seeing infomercials for weight loss products where people had really changed a lot. What was fascinating to me was actually that her body hadn't changed that much. It had changed in minor ways. And I liked the aesthetic changes, but I was like, I've been warned up and down how much lifting weights would do everything you didn't want.
She was here doing all of these things that I had been told not to do and she was not only fine, but she was so happy and having a great time.
But after looking at her pictures, I was like, she's not that different. And not only that — in her description of what she was doing, she was only working out three times a week. She was only doing five reps at a time of three movements for a few sets and then she was done. So that was taking her 30 minutes. She was eating way more than I was at that time.
She was here doing all of these things that I had been told not to do and she was not only fine, but she was so happy and having a great time.
Was there ever a point in your lifting journey where you felt concerned that you were pushing yourself just to push yourself like you had been in previous workout routines?
What I keep coming back to is that there are so many mechanisms that are inherently about building yourself up, about protecting yourself, and building a relationship with yourself, which really was the most important part of it to me.
There's this just atomic unit of lifting that I hadn't experienced in any other physical activity though, you could apply it, just no one does. But it was more built into lifting.
You would do a rep or do a set and ask yourself, 'How did that feel?' What was my experience of that? Was the weight too heavy? Was it too light? How did my forearm feel? Do I feel like I'm feeling this in the right muscles?
I was able to understand how I was feeling about so many other things in a way that I had never done before. - Casey Johnston
And a lot of these questions you don't know the answer at first and that is okay, but you're encouraged in this practice of inquiry of yourself and experience of something and that, to me, was so significant because pursuant to my personal background and pursuant to how a lot of us, but women especially, are treated in cultures to discourage inquiry of your experience. To push down whatever it is that you're feeling because someone else's feelings are more important, because someone else has greater needs than you. And that's not to say that you are the most important person in any room, but that this is an experience of yourself that radiates outward.
The experience of asking myself how I felt and lifting encouraged me to develop that practice more outside in the world and I was able to understand how I was feeling about so many other things in a way that I had never done before.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Six infants born with congenital measles in Ontario from unvaccinated mothers
Six infants born with congenital measles in Ontario from unvaccinated mothers

National Post

timean hour ago

  • National Post

Six infants born with congenital measles in Ontario from unvaccinated mothers

Ontario's chief medical officer of health says six infants have been born with congenital measles since an outbreak began last fall, adding they were infected in the womb through mothers who were not vaccinated. Article content Dr. Kieran Moore says these infants recovered, but their infections could have been prevented if their mothers had been vaccinated and protected from contracting measles. Article content Article content Article content Congenital measles can result in severe complications, including inflammation of the brain and death. Article content Article content In an interview with The Canadian Press, Moore says 40 pregnant people have been infected with measles in Ontario, and only two were vaccinated. Article content Moore suggests unvaccinated pregnant people isolate if they live in a community with active measles cases. Health officials have reported more than 2,000 cases in the province since the outbreak began in October. Article content The measles mumps and rubella (MMR) vaccine is not recommended once a person is pregnant because it contains a live virus that could theoretically be transmitted to the fetus. Article content Article content The National Advisory Committee on Immunization recommends unvaccinated pregnant people get one dose of intravenous immunoglobulin within six days if they are exposed to measles. Article content Article content However, Moore said that message faces hurdles similar to those around vaccine hesitancy. Article content 'Some people, if they don't want a vaccine, they may not want the immunoglobulin either. That may be a philosophical choice,' Moore said Friday. Article content In an editorial published Monday in the Canadian Medical Association Journal, Dr. Catherine Varner argues pregnant people are 'bearing the burden' of Canada's measles outbreak. Article content 'Pregnant people are often at higher risk than the general population in infectious disease outbreaks. As such, they cannot be an afterthought in preventive strategies and health-care systems' responses,' Varner writes. Article content Moore said the vast majority of pregnant people in Ontario are fully vaccinated against measles. Article content 'It's only a very small subgroup of people who have chosen not to get vaccinated who are having the complications,' he said. Article content 'I know some will concentrate on the glass being half-empty. You know, to have that level of protection in the face of the risks globally, I think is quite an accomplishment. Article content 'I'd love to have 100 per cent, but we have to work with these communities that have chosen not to be vaccinated, and that is a long and difficult conversation that I think all of our health-care workers are dedicated to having.' Article content

Insider Buying and Options Surge Spark Bullish Interest in UnitedHealth (UNH)
Insider Buying and Options Surge Spark Bullish Interest in UnitedHealth (UNH)

Globe and Mail

time2 hours ago

  • Globe and Mail

Insider Buying and Options Surge Spark Bullish Interest in UnitedHealth (UNH)

UnitedHealth Group (UNH) is drawing attention from traders after a spike in call option activity and notable insider buying. Despite the stock being down nearly 40% year-to-date, a weaker-than-expected Q1 earnings report, and a softer outlook, recent activity suggests growing confidence in a potential recovery. Confident Investing Starts Here: Heightened Activity Signals Bullish Sentiment On Thursday, more than 162,000 call options were traded on UNH. That's a 29% jump compared to the stock's typical daily call volume of around 126,000. This level of activity often reflects bullish expectations from traders anticipating upward price movement. Insiders are also showing conviction. On May 14, Director John H. Noseworthy purchased 300 shares at an average price of $312.16. Six days later, CEO Stephen Hemsley bought 86,700 shares at an average of $288.57 per share, totaling over $25 million. In total, insiders have acquired 109,408 shares over the past 90 days, worth approximately $31.6 million. Insider buying of this scale often signals confidence in long-term value. Institutional investors have also been increasing their exposure to these assets. Vanguard, Wellington Management, and Norges Bank all added to their positions last quarter. Institutional ownership now stands at 87.9%, highlighting continued support from long-term holders. Stock Rebounds Slightly as Fundamentals Show Mixed Signals The stock closed Friday at $303.22, up 2.49% on the day. It remains far below its 52-week high of $630.73 and just above the recent low of $248.88. At current levels, UNH has a market cap of about $275 billion, a P/E ratio of 14.11, and a dividend yield of 2.84%. The company recently raised its quarterly dividend to $2.21 per share. UnitedHealth posted Q1 revenue of $109.6 billion, slightly below consensus estimates. Earnings per share came in at $7.20, missing expectations of $7.29. While analysts still expect full-year EPS of $29.54, several firms have lowered their price targets in response to the softer results and rising sector concerns. Options market data reinforces the bullish tilt. The put/call ratio is 0.48, indicating more call buying than put buying. This ratio suggests traders are positioning for a potential rebound in the near term. In summary, while UnitedHealth continues to face pressure from weaker earnings and macroeconomic headwinds, the surge in call option activity, insider buying, and strong institutional support indicate renewed investor interest. Is UNH a Good Stock to Buy Right Now? According to The Street's analysts, UnitedHealth is a Moderate Buy. The average UNH price target is $369.73, implying a 21.93% upside. See more UNH analyst ratings Disclaimer & Disclosure Report an Issue

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System
Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Globe and Mail

time2 hours ago

  • Globe and Mail

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

HINGHAM, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY Endovascular Robotic System, today announced the continued expansion of its commercial team in preparation for the anticipated U.S. launch of the LIBERTY System, which is projected during the third quarter of 2025. The Company remains actively engaged with the U.S. Food and Drug Administration (FDA), with a 510(k) decision now expected during the third quarter of this year. This updated FDA decision timeline remains within the FDA's original scheduled review window and is not expected to affect the Company's planned launch upon clearance. 'Our recent interactions with the FDA have been productive, and we remain confident in the process and outcome,' said Harel Gadot, Chairman, CEO & President. 'We continue to operate with full momentum and position the Company for an anticipated launch during the third quarter of this year, which includes the continued build out of our commercial infrastructure and preparing the organization to deliver on our strategy.' As part of the Company's ongoing launch preparation, it recently expanded its commercial team with the addition of Michael Lytle as the head of Sales Operations & Analytics. Mr. Lytle brings deep experience in sales support, data analysis, and operational excellence. He is expected to play a key role in shaping market intelligence tools and processes to optimize the sales cycle and drive strategic growth. Prior to joining Microbot, Mr. Lytle held increasing leadership roles at ZOLL Cardiac Management Solutions (CMS), a division of ZOLL Medical Corporation, where he supported the rollout of innovative cardiac care technologies. 'We believe that Michael's addition will strengthen our launch readiness plans, and that his expertise will help us target the right markets, allocate resources effectively, and accelerate commercial execution,' concluded Mr. Gadot. The LIBERTY System is currently under FDA review, is not available for sales in the US, and clearance is not guaranteed. About Microbot Medical Microbot Medical Inc. (NASDAQ: MBOT) is a pre-commercial stage medical technology company with a vision to redefine endovascular robotics and improve the quality of care for millions of patients and providers globally. The Company has developed the world's first single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. Further information about Microbot Medical® is available at Safe Harbor Statements to future financial and/or operating results, future growth in research, technology, clinical development, commercialization and potential opportunities for Microbot Medical Inc. and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Any statements that are not historical fact (including, but not limited to statements that contain words such as 'will,' 'believes,' 'plans,' 'anticipates,' 'expects' and 'estimates') should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, the Company's need for and ability to obtain additional working capital to continue its transition to a commercially focused company, market conditions, risks inherent in the development and/or commercialization of the LIBERTY® Endovascular Robotic System, uncertainty in the results of regulatory pathways and regulatory approvals, including whether the FDA will timely grant 510(k) clearance to commercially market the LIBERTY® Endovascular Robotic System in the United States if at all, uncertainty resulting from political, social and geopolitical conditions, particularly any changes in personnel or processes or procedures at the FDA and announcements of tariffs on imports into the U.S., disruptions resulting from new and ongoing hostilities between Israel and the Palestinians and other neighboring countries, and maintenance of intellectual property rights. Additional information on risks facing Microbot Medical® can be found under the heading 'Risk Factors' in Microbot Medical's periodic reports filed with the Securities and Exchange Commission (SEC), which are available on the SEC's web site at Microbot Medical® disclaims any intent or obligation to update these forward-looking statements, except as required by law

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store